SambaNova
Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives
$350MSeries E
Role not disclosedTR
T. Rowe Price Associates
Activity from announced rounds
Activity in this selectionUnited States · Feb 28, 2026 · Feb 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $402M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionThird Arc Bio
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
$52MSeries A+
Role not disclosed